ISurTec
Private Company
Funding information not available
Overview
ISURTEC is a private, revenue-generating company that has established itself as a leader in biofriendly surface coatings since 2007. Its core business revolves around its ISURGLIDE® hydrophilic coatings, which are used on FDA-approved medical devices to reduce friction and tissue trauma. The company is expanding into the biopharma and diagnostics sectors with a pipeline of novel in vitro technologies, including ultra-low attachment and thermoresponsive cell culture surfaces, supported in part by NIH SBIR grants. With ISO 9001:2015 certification and a portfolio of proprietary coating chemistries, ISURTEC combines contract services with product sales to accelerate customer device development.
Technology Platform
Proprietary surface modification and coating platform encompassing lubricious hydrophilic coatings (ISURGLIDE), UV-cured primers for silicone (PHOTOPRIME), ultra-low attachment cell culture coatings (ISURCELL), thermoresponsive polymers (ISURTHERM), and protein-resistant (antibiofouling) coatings.
Opportunities
Risk Factors
Competitive Landscape
ISURTEC competes in the medical device coatings space against companies like DSM Biomedical, Hydromer, SurModics, and Biocoat. In the in vitro and cell culture segment, it faces giants such as Corning, Thermo Fisher Scientific, and Greiner Bio-One, which offer standard surface treatments. ISURTEC's differentiation lies in its specialized, high-performance chemistries and custom development capabilities for challenging applications.